Call for Expressions of Interest for Clinical Oncology and Surgery Representation on the BTOG Steering Committee: Learn more: https://www.btog.org/join-the-btog-steering-committee/ Deadline for submission of expression of interest is Monday 9th March 2026. #LCSM #LungCancer

🤝 BTOG Opening Session National and international updates from NLCA, BTS, UKLCC and IASLC to set the scene for #BTOG26. 🔗 https://www.btog.org/24th-btog-annual-conference-2026/#BTOG26 #LCSM

BTOG 2026 Awards - Nominations Now Open BTOG 2026 Nurse of the Year Award BTOG 2026 Doctor of the Year Award BTOG 2026 Young Researcher of the Year Award https://ow.ly/Ouly50XSPbj Closing date for nominations is Monday 9th February 2026. #LCSM #LungCancer

BTOG’s Latest Annual Report is now available. Find out what BTOG achieved during the year ended March 2025 under the 3 Pillars including education, research, representation https://www.btog.org/annual-reports/

🪨 #Mesothelioma Diagnostics Symposium From biomarkers and TNM9 staging to pleural space management — dedicated, practical updates at #BTOG26. 🔗 https://www.btog.org/24th-btog-annual-conference-2026/#Mesothelioma#BTOG26#LCSM

Impressive OS data from DELLphi-303: will Tarlatamab become standard of care in 1L SCLC? Tom Newsom-Davis and Shobhit Baijal discuss, in the BTOG 'ESMO Top 10' webcast Download the podcast or login to your BTOG account to watch https://ow.ly/CF0L50XR9ww Tom Newsom-Davis #LCSM #lungcancer

BTOG wishes to inform members of a new NICE release that has been published today for nivolumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancer. www.btog.org/new-guidance... #LCSM #LungCancer Image copyright NICE.

🩺 Radiotherapy Complex Cases MDT Small cell, thymic malignancies, brain metastases & Stage III disease — real-world decision making at #BTOG26. 🔗 https://www.btog.org/24th-btog-annual-conference-2026/#BTOG26 #LCSM

Read more about sustainability initiatives at our Annual Conference and your options for sustainable travel on our website https://www.btog.org/24th-btog-annual-conference-2026/#sustainability

🧠 SACT in CNS Disease Immunotherapy, targeted therapies and ADCs in brain metastases take focus in the Therapeutics Symposium. #BTOG26 🔗 https://www.btog.org/24th-btog-annual-conference-2026/#BTOG26 #LCSM

Call for Expressions of Interest for Clinical Oncology and Surgery Representation on the BTOG Steering Committee: Learn more: https://www.btog.org/join-the-btog-steering-committee/ Deadline for submission of expression of interest is Monday 9th March 2026. #LCSM #LungCancer

🧪 Diagnostics Symposium: Diagnostic Challenges Incidental findings, radiology dilemmas and managing synchronous lesions — a must-attend for MDTs. #BTOG26 🔗 https://www.btog.org/24th-btog-annual-conference-2026/#BTOG26 #LCSM

Will PD-1/VEGFR inhibition result in OS as well as PFS benefit in SqCC? Shobhit Baijal discusses the benefits, and risks, of ivonescimab in the HARMONi-6 trial in the BTOG 'ESMO Top 10' webcast Download the podcast or login to your BTOG account to watch https://ow.ly/rl5350XR9v1 #LCSM #lungcancer

BTOG 2026 Awards - Nominations Now Open BTOG 2026 Nurse of the Year Award BTOG 2026 Doctor of the Year Award BTOG 2026 Young Researcher of the Year Award https://ow.ly/Ouly50XSPbj Closing date for nominations is Monday 9th February 2026. #LCSM #LungCancer

🎯 Radiotherapy Symposium: Pushing the Boundaries in Lung Cancer SBRT, cardiac protection and LCT in EGFR-mutant disease — practical insights for modern practice. #BTOG26 🔗 https://www.btog.org/24th-btog-annual-conference-2026/#BTOG26 #LCSM

🔬 Therapeutics Symposium – Immune Cell Engagers From T-cell engagers to cancer vaccines and TIL therapy, explore what’s next in immunotherapy at #BTOG26. 🔗 https://www.btog.org/24th-btog-annual-conference-2026/#BTOG26 #LCSM

Call for Expressions of Interest for Clinical Oncology and Surgery Representation on the BTOG Steering Committee: Learn more: https://www.btog.org/join-the-btog-steering-committee/ Deadline for submission of expression of interest is Monday 9th March 2026. #LCSM #LungCancer

BTOG 2026 Awards - Nominations Now Open BTOG is inviting nominations for persons who have made a real difference to the care, treatment, or research for patients with thoracic malignancies. https://ow.ly/eGoh50XSP8a Closing date for nominations is Monday 9th February 2026. #LCSM #LungCancer

🧬 Therapeutics, Radiotherapy & Diagnostics take centre stage from day one at #BTOG26. Three parallel symposia, one goal: improving outcomes in lung cancer. 🔗 https://www.btog.org/24th-btog-annual-conference-2026/#BTOG26 #LCSM

Is sacituzumab-TMT a game-changer in post-TKI EGFR mutated lung cancer? Sharmistha Ghosh discusses the implications of the Opti-TROP Lung-04 study. Download the podcast or login to your BTOG account to watch BTOG 'ESMO Top 10' webcast https://ow.ly/IRKl50XR9tm #LCSM #lungcancer

📢 Registration is open for the 24th BTOG Annual Conference! Join us in Edinburgh, 4–6 March 2026, for cutting-edge science, debate and collaboration across thoracic oncology. 🔗 https://www.btog.org/24th-btog-annual-conference-2026/ #BTOG26 #LCSM #lungcancer

BTOG wishes to inform members of a new NICE release that has been published today. www.btog.org/amivantamab-... #LCSM

BTOG is pleased to highlight a new practical guide published in Clinical Oncology for providing post-operative radiotherapy to thymic epithelial tumours developed by our Thymic Malignancies Special Interest Group. www.btog.org/new-cli...

Our latest podcast is with @uklungcancer.bsky.social and discusses their recent conference looking at what's next. With @tnewsomdavis.bsky.social Emma O'Dowd David Gilligan. #LCSM #LungCancer Listen on Apple Podcasts, Spotify or Amazon Music (search 'BTOG') or our website www.btog.org/btog-podcasts/

Innovation drives progress. From clinical research to education, BTOG supports the lung cancer community in delivering better treatments and outcomes. #LungCancerAwareness #LCSM #LungCancer

BTOG is excited to share the 1st Release Draft Programme for #BTOG26 (subject to faculty confirmations). #LCSM btog.org/24th-btog-an...

Research isn’t separate from care - it is care. As Professor @drsanjaypopat.bsky.social reminds us, advancing #lungcancer research is how we deliver the best possible treatment, outcomes & hope. Support research. Share stories. Drive change. #StoriesOfLungCancer #LCAM25 @btog.bsky.social

Early detection saves lives. Screening, research and collaboration are key to tackling lung cancer. BTOG is committed to advancing knowledge and improving care across the UK. #LungCancerAwareness #LCSM #LungCancer

⏳ 1 week to go! We’re nearly there — a full day on non-smoking lung cancer: from diagnosis to survivorship. With @ruthstraussfdn.bsky.social Still time to register 👉 🔗 www.btog.org/non-smo... 📅 Thurs 13 Nov | 📍 London #LungCancer #LCSM #NonSmokingLungCancer

Just out: ESMO Top 10 Abstracts Webcast & Podcast The rationale and design, efficacy, side effects & potential impact with: @tnewsomdavis.bsky.social Dr Shobhit Baijal & Dr Sharmistha Ghosh. Video webcast is members only, audio podcast open access. Details: www.btog.org/esmo25-top10-webcast/

💭 What’s in a name? Martin Forster opens the event exploring how we label non-smoking lung cancer — and why it matters. 📅 Join us 13 Nov, London 🔗 www.btog.org/non-smo... #Oncology #LungCancer

New #podcast release: BTOG does … Chemo RT: What to do in unresectable disease Dr Emma O'Dowd talks to Dr Clive Peedell, Consultant Clinical Oncologist, James Cook University Hospital. Search BTOG in App Store/Spotify/Amazon Music or listen via BTOG website www.btog.org/btog-po...#podcast #LCSM

✅ CPD credits (applied for) ✅ Patient voice ✅ Groundbreaking science 🎟️ Join the BTOG Non-Smoking Lung Cancer Essential Update with @ruthstraussfdn.bsky.social 📅 13 Nov, London 🔗 www.btog.org/non-smo... #LungCancer #LCSM #NonSmokingLungCancer

BTOG wishes to inform members of a new @nicecomms.bsky.social release published today. NICE has recommended Lorlatinib as an option for ALK-positive advanced non-small-cell lung cancer in adults who have not had an ALK inhibitor. More details www.nice.org.uk/guidance/TA1... #LCSM #LungCancer

👥 Meet the experts: 🧑‍⚕️ @tnewsomdavis.bsky.social 🧑‍⚕️ Martin Forster and many more with @ruthstraussfdn.bsky.social at #NonSmokingLungCancer. A full day of learning and networking awaits. 📆 13 Nov 🔗 www.btog.org/non-smo...#NonSmokingLungCancer.#LungCancer #LCSM #NonSmokingLungCancer

Screening Event 🎉 Today’s the day! The #BTOGScreeningEvent kicks off in London with vital updates on #LungCancer screening across the UK. We’ll be talking strategy, challenges, and the future of screening. Follow along and join the conversation ⬇️ #BTOGScreeningEvent #LCSM

The October NLCA newsletter is out now! Read about our QI intervention, upcoming State of the Nation report and more…! www.natcan.org.uk/news/nlca-ne... @hqip.bsky.social @btog.bsky.social #LungCancer

The NLCA October quarterly data dashboard is now live! This includes the latest English data up to 31 Dec 2024: rcs-ceu.shinyapps.io/NLCA/ @hqip.bsky.social @btog.bsky.social #LungCancer

We’re ready. Are you? 👥 Meet national experts 🧠 Debate real-world screening issues 🗣️ Submit your questions live 📍London | ⏰ Doors open 08:30 See you tomorrow at the #BTOGScreeningEvent #LungCancer #LCSM

💡 Discover the latest in mutation-driven lung cancer research. Session 4 with @ruthstraussfdn.bsky.social rings science, debate, and progress together. 📅 13 Nov | 📍 The View, London 🔗 www.btog.org/non-smo... #LungCancer #LCSM #NonSmokingLungCancer

1 week to go! ⏳ The #BTOGScreeningEvent is almost here. Join the lung cancer screening community in London for vital updates, peer discussions, and practical challenges. Don’t miss it — register today: www.btog.org/btog-sc...#BTOGScreeningEvent#LungCancer #LCSM

"🧩 Local Consolidative Therapy – survival benefits or overtreatment? Hear from experts tackling difficult questions in non-smoking lung cancer. 🎫 Register today 🔗 www.btog.org/non-smo... #LungCancer #LCSM #NonSmokingLungCancer With @RuthStraussFdn"

Registration and abstract submissions are now open for #BTOG26 our 24th Annual Conference, which will be held at the EICC in Edinburgh. Full details are on the website www.btog.org/24th-btog-an... #LCSM #lungcancer

Ruth Strauss Foundation have grants up to £50,000 available for research into Non-Smoking #LungCancer; to improve understanding, diagnosis & quality of life 🫁 🗓️ Apply by 10 Jan 2026 #LCSM ruthstraussfoundation.com/grants-progr...

♟️ CheckMate for perioperative nivolumab? Dr. Jonathan Spicer presented the latest data from the CheckMate 77T trial at #WCLC25. 🔗 Read more in ILCN: bit.ly/46m612v

"Psychological distress in screening is real. How can we recognise & manage it effectively? Join the discussion at #BTOGScreeningEvent ✅ Full programme: www.btog.org/btog-sc...#BTOGScreeningEvent#LungCancer #LCSM "

"🔍 Brain metastases + the DVLA – treatment implications for your practice. Don’t miss this timely session in our Advanced Disease module. 📍 London | 📅 13 Nov #LungCancer #LCSM #NonSmokingLungCancer 🔗 www.btog.org/non-smo...#LungCancer#LCSM#NonSmokingLungCancerth @RuthStraussFdn"

"Peer support is vital in lung cancer screening delivery. Our fireside chat will feature first-hand insights from teams on the ground — with real-world Q&A from attendees. 🗓️ 14 Oct 2025 | 💬 Bring your questions! #LungCancer #LCSM #BTOGScreeningEvent "

"🧠 MRD: Molecular Residual Disease – is it ready for clinical use in early NSCLC? Get the latest on 13 Nov with @RuthStraussFdn. 🔗 www.btog.org/non-smo... #LungCancer #LCSM #NonSmokingLungCancer"

New Podcast Alert! BTOG does … Neo-adjuvant / peri-operative chemoimmunotherapy @tnewsomdavis.bsky.social & Emma O'Dowd talk to Jason Adhikaree. Subscribe via Apple App Store, Spotify or Amazon Music – just search BTOG or listen via the BTOG website. www.btog.org/btog-podcasts/ #LCSM #lungcancer